ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Philippine officials pull Dengvaxia's marketing license, but Sanofi asks them to reconsider
February 24, 2019Sanofi set off an uproar in the Philippines with its 2017 disclosure that dengue shot Dengvaxia can cause more serious infections in some cases. Now, after investigations and more, the country’s FDA has permanently revoked the vaccine’s marketing license.
Pharma Sources Insight January 2025
